EVALUATION OF THE THERAPEUTIC AND PREVENTIVE POTENTIAL OF THE MEDICINAL PRODUCT CANEPHRON N IN THE TREATMENT OF GESTATIONAL PYELONEPHRITIS IN PREGNANT WOMEN
Background: Gestational pyelonephritis (GP) is one of the most common and serious diseases of the middle and second half of pregnancy, which complicates approximately 6 % of pregnancies, and is one of the leading causes of non-obstetric pre-delivery hospitalization.
Methods. The paper provides data from the open, multicentre, prospective, comparative (parallel group) study in 60 pregnant women diagnosed with gestational pyelonephritis, which were divided into two groups 30 subjects each. Patients in the treatment group received antibacterial therapy for 7 days + treatment with standard dosage of medicinal product Canephron N for 3 months. Patients in the control group received antibiotic therapy alone for 7 days.
Results. The average age of pregnant women at the time of diagnosing was 23Â±6.23 years; it was the first pregnancy for 39 women (65 %). The most common complaints at admission to the in-patient department were as follows: lumbar pain (96.2 %), dysuria (70.2 %), rise in temperature above 38Â°C (64.4 %). Leukocyturia and bacteriuria were detected in 100 % of cases with prevalence of E. coli in 84.2 % (101 of 120) of cases. By 30 day in GP patients in the treatment group bacteriuria was detected in 2/30 (6.67 %) patients, and in the control group â€“ in 5/30 (16.7 %) patients (p 1: 2 <0.05), by 60 day in the treatment group â€“ 2/30 (6.67 %), in the control group â€“ 8/30 (26.7 %) (p 1: 2 <0.05), respectively, by 90 day â€“ 3/30 (10 %) and 10 (33.3 %), respectively (p 1: 2 <0.05). The disease relapsed in 1 of 30 (3.33 %) GP patients in the treatment group and 3/30 (10 %) patients in the control group (p 1: 2 <0.05) and 3/30 (10 %) patients in the treatment group with CP, and 7/30 (23.3 %) patients in the control group during the follow-up period (p 1: 2 <0.05).
The use of the herbal medicinal product Canephron N in pregnant women with gestational pyelonephritis and in the acute exacerbations of chronic pyelonephritis has shown its high efficacy and undoubted therapeutic and prophylactic effect, good tolerability and decrease in the frequency of relapses of pyelonephritis.
Ailamazyan, E. K., Kulakov, V. I., Radzinsky, V. E., Savelyeva, G. M. (2009). Obstetrics. National Guidelines. Moscow: “GEOTAR-Media”, 1200.
Gilstrap, L. C., Cunningham, F. G., Whalley, P. J. (1981). Acute pyelonephritis in pregnancy: an anterospective study. Obstetrics and Gynecology, 57 (4), 409–413.
Hammond, N. A., Nikolaidis, P., Miller, F. H. (2012). Infectious and Inflammatory Diseases of the Kidney. Radiologic Clinics of North America, 50 (2), 259–270. doi: 10.1016/j.rcl.2012.02.002
Stevens, P. E. (2013). Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline. Annals of Internal Medicine, 158 (11), 825. doi: 10.7326/0003-4819-158-11-201306040-00007
Kulakova, V. I., Serov, V. N. (2008). Medicinal products used in obstetrics and gynaecology. Moscow: “GEOTAR-Media”, 384.
Kenzaka, T., Kato, K., Kitao, A., Kosami, K., Minami, K., Yahata, S. et. al. (2015). Hyperammonemia in Urinary Tract Infections. PLOS ONE, 10 (8), e0136220. doi: 10.1371/journal.pone.0136220
Tessema, J., Jefferds, M. E., Cogswell, M., Carlton, E. (2009). Motivators and Barriers to Prenatal Supplement Use among Minority Women in the United States. Journal of the American Dietetic Association, 109 (1), 102–108. doi: 10.1016/j.jada.2008.10.013
Kumar, S., Dave, A., Wolf, B., Lerma, E. V. (2015). Urinary tract infections. Disease-a-Month, 61 (2), 45–59. doi: 10.1016/j.disamonth.2014.12.002
Wing, D. A., Rumney, P. J., Preslicka, C. W., Chung, J. H. (2008). Daily Cranberry Juice for the Prevention of Asymptomatic Bacteriuria in Pregnancy: A Randomized, Controlled Pilot Study. The Journal of Urology, 180 (4), 1367–1372. doi: 10.1016/j.juro.2008.06.016
Hill, J. B., Sheffield, J. S., McIntire, D. D., Wendel, G. D. (2005). Acute Pyelonephritis in Pregnancy. Obstetrics & Gynecology, 105 (1), 18–23. doi: 10.1097/01.aog.0000149154.96285.a0
Dalal, S., Nicolle, L., Marrs, C. F., Zhang, L., Harding, G., Foxman, B. (2009). Long‐TermEscherichia coliAsymptomatic Bacteriuria among Women with Diabetes Mellitus. Clinical Infectious Diseases, 49 (4), 491–497. doi: 10.1086/600883
Oktar, S. Ö., Yücel, C., Özdemir, H., Karaosmanoglu, D. (2004). Doppler Sonography of Renal Obstruction. Journal of Ultrasound in Medicine, 23 (7), 929–936. doi: 10.7863/jum.2004.23.7.929
Geerlings, S. E. (2008). Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. International Journal of Antimicrobial Agents, 31, 54–57. doi: 10.1016/j.ijantimicag.2007.07.042
Kokrdová, Z., Pařízek, A., Koucký, M., Pašková, A., Boudová, B. (2016). Septic shock in pregnancy on the basis of an acute pyelonephritis. Ceska Gynekol, 81 (4), 286–288.
Matuszkiewicz-Rowińska, J., Małyszko, J., Wieliczko, M. (2015). State of the art paper Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Archives of Medical Science, 1, 67–77. doi: 10.5114/aoms.2013.39202
Jepson, R. G., Williams, G., Craig, J. C. (2012). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.cd001321.pub5
Pazos Otero, N., Fuentes Ricoy, L., Ferrández Pérez, B., Martínez Vázquez, C., Martínez Poch, M., Osuna Díaz, J. L. (2007). Pyelonephritis and pregnancy. Our experience in a general hospital. Anales de Medicina Interna, 24 (12), 585–587.
Sheiner, E., Mazor-Drey, E., Levy, A. (2009). Asymptomatic bacteriuria during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine, 22 (5), 423–427. doi: 10.1080/14767050802360783
Smaill, F. M., Vazquez, J. C. (2015). Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.cd000490.pub3
Ailomazyan, E. K. (1999). Obstetrics. Saint-Petersburg, 850.
Copyright (c) 2018 Roman Sheremeta, Maksim Sabadash, Alexander Shulyak
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.